Glase v. Joshi

2025 Ohio 4438
CourtOhio Court of Appeals
DecidedSeptember 23, 2025
DocketL-24-1151
StatusPublished

This text of 2025 Ohio 4438 (Glase v. Joshi) is published on Counsel Stack Legal Research, covering Ohio Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Glase v. Joshi, 2025 Ohio 4438 (Ohio Ct. App. 2025).

Opinion

[Cite as Glase v. Joshi, 2025-Ohio-4438.]

IN THE COURT OF APPEALS OF OHIO SIXTH APPELLATE DISTRICT LUCAS COUNTY

Jeffrey Glase Court of Appeals No. L-24-1151

Appellant Trial Court No. CI0202301552

v.

Mandar M. Joshi, M.D. DECISION AND JUDGMENT

Appellee Decided: September 23, 2025

*****

Anthony J. Richardson, II, and Anthony J. Glase, for appellant.

Brian D. Sullivan, Robert D. Wagner, and Brianna M. Prislipsky, for appellee.

***** SULEK, P.J.

{¶ 1} In this medical malpractice action, appellant, Jeffrey Glase, appeals a

judgment of the Lucas County Court of Common Pleas awarding summary judgment in

favor of appellee, Mandar M. Joshi, M.D. Because the trial court erred by excluding

Glase’s expert’s opinion and the judgment fails to address the admissibility of the

expert’s post-deposition affidavit and report, the judgment is reversed. I. Facts and Procedural History

{¶ 2} The underlying facts are undisputed. On December 2, 2020, Glase

complained to his treating ophthalmologist of vision changes in his left eye which were

also observed while using the Amsler grid.1 The next day, Glase had his initial

appointment at Retina Vitreous Associates (RVA) for an age-related macular

degeneration (AMD) evaluation with Dr. Joshi, an ophthalmologist-trained retinal

specialist. Glase complained of worsening, decreased vision in his eye describing it as a

dark spot in his vision. The evaluation consisted of vision testing, pressure testing,

anterior segment examination, dilation, posterior segment examination, and imaging. Dr.

Joshi diagnosed Glase with early dry AMD in both eyes. AMD can be classified as dry

or wet. Dry AMD consists of deposits on the retina while wet AMD is diagnosed by the

presence of vessels leaking blood or fluid and can cause vision loss. Dry AMD can

progress to wet AMD.

{¶ 3} Glase was instructed to follow up in one year, but to call the office

immediately upon noticing any vision changes. Staff gave him an AMD pamphlet,

recommended he take AREDS 2 vitamins, and instructed him on daily use of the Amsler

grid.

{¶ 4} Glase returned to the office on October 28, 2021, after noting a sudden

vision change in his left eye five days prior. Dr. Joshi diagnosed Glase with very early

1 In his deposition, Dr. Joshi described the Amsler grid as a piece of paper with a grid pattern that aids in uncovering retinal distortion, a potential symptom of wet AMD.

2. wet AMD and resulting vision loss, and he injected Glase’s left eye with EYLEA, a

stabilizing treatment that targets a substance produced by wet AMD. When Glase

returned the next month, his vision had stabilized and he received a second EYLEA

injection. In Dr. Joshi’s experience, approximately 90 per cent of the time the injections

can stabilize vision within three lines of the eye chart. A patient can be treated with

EYLEA injection treatments for several years.

{¶ 5} In December 2021, Dr. Joshi left RVA. Glase received AMD treatment at

RVA through March 2022. Glase saw Dr. Ahmed Alkaliby who administered three

additional monthly EYLEA injections. From his final appointment with Dr. Joshi on

November 29, 2021, to his first visit with Dr. Alkaliby on December 27, 2021, Glase’s

left-eye vision worsened from 20/100 to 20/400.

{¶ 6} On February 14, 2023, Glase commenced the present action against Dr.

Joshi alleging medical negligence and intentional and negligent infliction of emotional

distress. Specifically, Glase claimed that Dr. Joshi negligently failed to diagnose and

treat his AMD resulting in permanent left-eye vision loss.

{¶ 7} On April 20, 2023, Dr. Joshi moved to dismiss Glase’s emotional distress

claims in count No. 2, as being duplicative of count No. 1. He explained that Ohio law

treats emotional distress claims stemming from medical care and treatment as medical

claims. The trial court agreed and dismissed the claims

{¶ 8} Glase filed the October 24, 2023 deposition of his expert, Dr. Robert Bloom,

a general ophthalmologist, pediatric fellowship trained, who treats both adults and

3. children. Dr. Bloom testified that 40 to 50 per cent of his patients are over 65 years old

and that he treats retinal diseases, including AMD. He stated that approximately 12 per

cent of his patients have AMD, most having dry AMD. Bloom stated that he generally

treats his wet AMD patients but will refer a patient to a retina specialist if they do not

show improvements following injections. Taking ER call shifts, Dr. Bloom sees

approximately one to two patients weekly with dry AMD that has converted to wet

AMD.

{¶ 9} Dr. Bloom opined that Dr. Joshi violated the standard of care by not

instructing Glase to return in four to six months for monitoring. Dr. Bloom addressed

questions regarding causation as follows:

Q: Doctor, as I understand, your one criticism is that he should have seen the patient within four to six months after that initial visit. If, in fact, Dr. Joshi had seen the patient, that doesn’t guarantee that the outcome would have changed in this particular patient?

A: No. But, again, if he – who’s to say? I mean, a lot of times you’ll see those blood vessels form and then you can treat him.

Q: Doctor, can you say in terms of medical certainty and probability that if, in fact, Dr. Joshi had seen the patient within the four to six months, as you had recommended, whether or not the patient’s vision would be saved and/or you can’t tell me?

A: Well, that’s why you do that. That’s the whole point of seeing patients back.

Q: In terms of medical certainty and probability, can you tell me whether or not the patient’s vision would have been saved or preserved?

A: You can’t.

Q: You don’t know. You can’t?

4. A: You lost that opportunity.

...

Q: And you’ve indicated that even if the patient had been seen by Dr. Joshi at four to six months, you don’t know if Dr. – if the outcome would have been any different in this case? . . . [T]he question is, whether it made – can you tell me in terms of certainty and probability whether it would have made a difference, and I think you said before that you cannot answer that question.

A: Well, because you can’t – you don’t always see it, so you’re right. Some people with macular degeneration, you have no clue.

Dr. Bloom agreed that “everything was done appropriately except the follow-up care.”

{¶ 10} Dr. Joshi’s expert, retina specialist Dr. Suber Huang, testified by affidavit

that after reviewing Glase’s complaint and affidavit of merit, deposition, and RVA

medical records, in his opinion, made with “the highest degree of medical certainty,” Dr.

Joshi “met or exceeded the standard of care” in Glase’s diagnosis and treatment. Dr.

Huang stated that during Glase’s December 3, 2020 initial visit there were no signs or

symptoms warranting treatment and that a follow-up interval of one year was appropriate.

{¶ 11} Dr. Joshi moved for summary judgment on the basis that Glase failed to

provide expert testimony supporting the elements of his claim, especially causation.

While the motion was pending, Joshi moved to exclude Glase’s expert Dr. Robert

Bloom’s deposition testimony asserting that as a pediatric ophthalmologist he was not

qualified under Evid.R. 601(B) to render an expert opinion as to whether Dr. Joshi, a

retinal specialist, violated the standard of care.

5.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pettiford v. Aggarwal
2010 Ohio 3237 (Ohio Supreme Court, 2010)
Duck v. Cantoni
2013 Ohio 351 (Ohio Court of Appeals, 2013)
Guiliani v. Shehata
2014 Ohio 4240 (Ohio Court of Appeals, 2014)
Steele v. Buxton
639 N.E.2d 861 (Ohio Court of Appeals, 1994)
Starkey v. St. Rita's Medical Center
690 N.E.2d 57 (Ohio Court of Appeals, 1997)
Schutte v. Mooney
844 N.E.2d 899 (Ohio Court of Appeals, 2006)
Medina v. Harold J. Becker Co., Inc.
840 N.E.2d 1112 (Ohio Court of Appeals, 2005)
Smith v. Promedica Health, Unpublished Decision (8-17-2007)
2007 Ohio 4189 (Ohio Court of Appeals, 2007)
Purcell v. Norris, Unpublished Decision (3-28-2006)
2006 Ohio 1473 (Ohio Court of Appeals, 2006)
Taulbee v. Dunsky, Unpublished Decision (11-10-2003)
2003 Ohio 5988 (Ohio Court of Appeals, 2003)
Miller v. Toledo Hosp.
2017 Ohio 2691 (Ohio Court of Appeals, 2017)
Bolen v. Mohan
2017 Ohio 7911 (Ohio Court of Appeals, 2017)
Bruni v. Tatsumi
346 N.E.2d 673 (Ohio Supreme Court, 1976)
Alexander v. Mt. Carmel Medical Center
383 N.E.2d 564 (Ohio Supreme Court, 1978)
Stinson v. England
633 N.E.2d 532 (Ohio Supreme Court, 1994)
Roberts v. Ohio Permanente Medical Group, Inc.
668 N.E.2d 480 (Ohio Supreme Court, 1996)
Bliss v. Johns Manville
2022 Ohio 4366 (Ohio Supreme Court, 2022)
Waetcher v. Laser Spine Inst., L.L.C.
2023 Ohio 3715 (Ohio Court of Appeals, 2023)
Bender v. Durrani
2024 Ohio 1258 (Ohio Court of Appeals, 2024)
Schmidt v. Crayne
2024 Ohio 4726 (Ohio Court of Appeals, 2024)

Cite This Page — Counsel Stack

Bluebook (online)
2025 Ohio 4438, Counsel Stack Legal Research, https://law.counselstack.com/opinion/glase-v-joshi-ohioctapp-2025.